Valuation Johnson & Johnson

Equities

Real-time Estimate Cboe BZX Other stock markets 21:32:19 06/03/2026 +03			5-day change	1st Jan Change
238.82 ^USD	-0.34%		-3.86%	+15.41%

05:01pm	Halozyme Therapeutics Says Johnson & Johnson Wins FDA Approval for Blood Cancer Treatment	MT
04:46pm	Oil Shock Meets Job Shock

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	448,463	461,875	376,932	349,226	500,242	577,484	-	-
Change	-	2.99%	-18.39%	-7.35%	43.24%	15.44%	-	-
Enterprise Value (EV) ¹	450,606	478,015	383,337	361,338	528,042	595,471	583,545	587,884
Change	-	6.08%	-19.81%	-5.74%	46.14%	12.77%	-2%	0.74%
P/E ratio	21.8x	26.2x	11.4x	25.1x	18.8x	24.4x	22.5x	21.7x
PBR	6.05x	6.13x	5.83x	4.88x	6.14x	6.6x	5.86x	5.36x
PEG	-	-1.9x	0x	-0.4x	0.2x	-2.2x	2.72x	5.49x
Capitalization / Revenue	4.78x	4.86x	4.43x	3.93x	5.31x	5.74x	5.44x	5.13x
EV / Revenue	4.81x	5.03x	4.5x	4.07x	5.61x	5.92x	5.5x	5.22x
EV / EBITDA	12.3x	14.6x	12.6x	12.3x	15.9x	16.1x	14.8x	13.9x
EV / EBIT	15.4x	16x	14x	13.7x	17.4x	17.8x	16.2x	14.9x
EV / FCF	22.8x	27.8x	21x	18.2x	26.8x	23.7x	22.1x	20.2x
FCF Yield	4.38%	3.6%	4.76%	5.49%	3.73%	4.22%	4.52%	4.94%
Dividend per Share ²	4.19	4.45	4.7	4.91	5.14	5.299	5.598	5.737
Rate of return	2.46%	2.52%	3%	3.39%	2.48%	2.21%	2.34%	2.39%
EPS ²	7.81	6.73	13.72	5.79	11.03	9.823	10.64	11.06
Distribution rate	53.6%	66.1%	34.3%	84.8%	46.6%	53.9%	52.6%	51.9%
Net sales ¹	93,775	94,943	85,159	88,821	94,193	100,616	106,127	112,631
EBITDA ¹	36,634	32,630	30,414	29,288	33,261	36,932	39,361	42,298
EBIT ¹	29,244	29,965	27,460	26,466	30,358	33,444	36,102	39,381
Net income ¹	20,878	17,941	35,153	14,066	26,804	23,635	25,199	26,574
Net Debt ¹	2,143	16,140	6,405	12,112	27,800	17,987	6,061	10,400
Reference price ²	170.35	176.66	156.58	145.05	207.63	239.63	239.63	239.63
Nbr of stocks (in thousands)	2,632,597	2,614,484	2,407,279	2,407,623	2,409,295	2,409,899	-	-
Announcement Date	1/25/22 A	1/24/23 A	1/23/24 A	1/22/25 A	1/21/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JOHNSON & JOHNSON	24.39x	5.92x	16.12x	2.21%	577B
ELI LILLY AND COMPANY	28.9x	10.89x	21.87x	0.67%	878B
ABBVIE INC.	25.23x	6.89x	13.83x	2.98%	411B
ROCHE HOLDING AG	18.73x	4.61x	11.4x	2.86%	359B
ASTRAZENECA PLC	24.72x	5.15x	14.27x	1.69%	305B
NOVARTIS AG	21.6x	5.83x	14.37x	2.77%	304B
MERCK & CO., INC.	27.13x	4.76x	14.87x	2.91%	287B
AMGEN INC.	24.73x	6.28x	11.17x	2.73%	198B
GILEAD SCIENCES, INC.	20.12x	6.12x	11.07x	2.24%	180B
NOVO NORDISK A/S	11.75x	4.26x	8.81x	4.34%	171B
Average	22.73x	6.07x	13.78x	2.54%	367.05B
Weighted average by Cap.	24.24x	6.88x	15.53x	2.18%